Triptolide Inhibits the AR Signaling Pathway to Suppress the Proliferation of Enzalutamide Resistant Prostate Cancer Cells

Enzalutamide is a second-generation androgen receptor (AR) antagonist for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Unfortunately, AR dysfunction means that resistance to enzalutamide will eventually develop. Thus, novel agents are urgently needed to treat this devast...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Yangyang, Huang, Weiwei, Liu, Jiakuan, Liu, Dandan, Cui, Yangyan, Huang, Ruimin, Yan, Jun, Lei, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479278/
https://www.ncbi.nlm.nih.gov/pubmed/28638477
http://dx.doi.org/10.7150/thno.17852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479278/
https://www.ncbi.nlm.nih.gov/pubmed/28638477
http://dx.doi.org/10.7150/thno.17852

Ejemplares similares